# Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

> **NCT03335501** · PHASE2 · WITHDRAWN · sponsor: **Institut de Recherches Cliniques de Montreal**

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Insulin pump
- **DEVICE:** Continuous glucose monitoring system
- **OTHER:** 11-hour intervention with the single-hormone artificial pancreas

## Key facts

- **NCT ID:** NCT03335501
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-04-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The owner of the algorithm does not wish that this study be undertaken
- **Last updated:** 2018-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03335501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03335501, "Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03335501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*